Status:
TERMINATED
Risk Factors for COVID-19 Mortality
Lead Sponsor:
Teodoro Marcianò
Conditions:
COVID-19 Virus Infection
Population at Risk
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symp...
Eligibility Criteria
Inclusion
- Admission to the Emergency Medicine Ward from the Emergency Department of Piacenza Hospital (Italy)
- Confirmed COVID-19 diagnosis through molecular test obtained from nasal-pharyngeal swabs in the Emergency Department
- Age above 18
Exclusion
- inability to obtain an informed consent due to neurological conditions.
- patient's refusal to sign the informed consent
- inability of researchers to recruit the patient in the first 24 hours from the admission.
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04786808
Start Date
January 15 2021
End Date
November 7 2021
Last Update
November 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL di Piacenza
Piacenza, Emilia-Romagna, Italy, 29121